ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1080

B-Cell Clonal Expansions in Parotid Glands of Sjogren’s Patients Are Associated with Increased Numbers of N-Glycosylation Motifs in the Immunoglobulin Heavy Chain Genes

Annie Visser1, Marieke E. Doorenspleet2, Niek de Vries3, Fred K.L. Spijkervet4, Arjan Vissink5, Hendrika Bootsma6, Frans G.M. Kroese1 and Nicolaas A Bos1, 1Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 2Dept. of Clinical Immunology & Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, 3Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, 4Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 5Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 6Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, The Netherlands, Groningen, Netherlands

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: B cells, immunoglobulin (IG) and salivary gland, RNA, Sjogren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: B Cell Biology and Targets in Autoimmune Disease - Poster I: SLE and Sjögren's

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:  Primary Sjögren’s syndrome (pSS) is a systemic autoimmune disease characterized by chronic inflammation of salivary and lacrimal glands. Patients with pSS have increased clonal expansions of B-cells in glandular tissue. The driving force for this expansion is unknown. Previous Ig heavy chain (IGHV) analysis studies of both parotid and labial glands revealed that there are no indications for an antigen driven expansion. However, our sequence analysis of RNA transcripts encoding for IGHV3 (IGHV3) genes derived from parotid pSS B-cell clones revealed significantly higher incidence of acquired N-glycosylation sites due to somatic hypermutation, suggesting a role for N-glycosylation motifs (N-glycs) in the selection of Ig producing cells. The aim of this study was to assess clonal expansions with Next Generation Sequencing (NGS) technology for all IGHV family genes in parotid gland tissue derived from pSS and non-pSS sicca patients.

Methods:  mRNA was isolated from biopsies of parotid glands of 5 pSS patients diagnosed according to the AECG criteria and 5 non-pSS sicca patients. IGHV sequences of all IGHV families were amplified and sequenced using NGS. The Ig sequences were analyzed for IGHV gene usage, somatic hypermutation, CDR3 length and rearrangement by alignment with germline gene sequences of the IMGT reference directory. Sequences with the same CDR3 region (amino acids) and shared mutations within the Ig variable region were referred to as clonally related. Clones composed of more than ≥0.3% of the total amount of productive sequences were referred to as dominant clones. These clones were analyzed for expansion patterns, signs of antigen selection and acquired N-glycs.

Results:  From each patient 1800-4000 unique sequences were recovered. We observed no difference in IGHV gene usage or CDR3 length between the pSS and non-pSS IGHV sequences. A total of 70 dominant clones (mean 14.0±5.6 clones) was found in pSS biopsies, whereas in non-pSS biopsies a significantly lower (p=0.0079) number of 15 dominant clones was detected (mean 3.0±1.6 clones). No difference in percentage of mutations was seen between dominant clones from pSS and non-pSS patients. Analysis of dominant clones showed that in 4 of the 5 pSS patients, and in none of the clones of the non-pSS patients, the germline sequence was present in some of the clones. There was no evidence for antigen driven selection in the dominant clones. We observed that the IGHV sequences of dominant clones in pSS patients had acquired significantly more N-glycs compared to non-pSS sicca patients. These N-glycs were not restricted to IGHV3 genes. Remarkably, the majority of N-glycs was seen in the framework 3 region of IGHV3.

Conclusion:  The presence of germline and heavily mutated IGHV sequences in dominant clones in parotid gland tissue of Sjögren patients is direct evidence that naïve B-cells entering the parotid gland expand and differentiate locally into plasma cells. Lack of evidence for antigen-driven clonal expansion in conjunction with significantly higher incidence of N-glycs, outside the antigen-binding site, in these clones suggests an alternative selection of Ig producing B-cells in pSS. We postulate that there might be a possible role for lectins in this process.


Disclosure: A. Visser, None; M. E. Doorenspleet, None; N. de Vries, None; F. K. L. Spijkervet, None; A. Vissink, None; H. Bootsma, None; F. G. M. Kroese, None; N. A. Bos, None.

To cite this abstract in AMA style:

Visser A, Doorenspleet ME, de Vries N, Spijkervet FKL, Vissink A, Bootsma H, Kroese FGM, Bos NA. B-Cell Clonal Expansions in Parotid Glands of Sjogren’s Patients Are Associated with Increased Numbers of N-Glycosylation Motifs in the Immunoglobulin Heavy Chain Genes [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/b-cell-clonal-expansions-in-parotid-glands-of-sjogrens-patients-are-associated-with-increased-numbers-of-n-glycosylation-motifs-in-the-immunoglobulin-heavy-chain-genes/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/b-cell-clonal-expansions-in-parotid-glands-of-sjogrens-patients-are-associated-with-increased-numbers-of-n-glycosylation-motifs-in-the-immunoglobulin-heavy-chain-genes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology